The research group is mainly based at the Norwegian Radium Hospital and Oslo University. However, the group has a node at the Karolinska Institutet and maintain strong interactions with three research networks at the Karolinska Institutet: Immunomodulatory Therapies for Autoimmity and Cancer (IMTAC), Theme Center for Regenerative Medicine and Center for Infectious Medicine (CIM). The PI and some group members have double affiliation to CIM.